Targeting the Gut-Liver Axis: How Probiotics and Synbiotics Reduce Hepatic Inflammation and Restore Glycemic Control
Clinical evidence confirms targeted probiotic and synbiotic therapy lowers ALT, AST, and TNF-alpha while enhancing glycemic stability in metabolic liver dysfunction.
